Artículos de revistas
The Impact Of Cystic Fibrosis On The Immunologic Profile Of Pediatric Patients
Registro en:
Jornal De Pediatria. , v. 89, n. 1, p. 40 - 47, 2013.
217557
10.1016/j.jped.2013.02.007
2-s2.0-84875264276
Autor
Bernardi D.M.
Ribeiro A.F.
Mazzola T.N.
Vilela M.M.S.
Sgarbieri V.C.
Institución
Resumen
Objective: To compare the immunologic state of 44 pediatric patients with cystic fibrosis (CF) with a control group consisting of 16 healthy individuals. Methods: CF patients aged 3 to 12 years with moderate to good clinical score were selected for the study. Erythrocytic glutathione, production of reactive oxygen species, cytokines (TNF-α, IFN-γ, IL-8, IL-6, IL-10) in peripheral blood mononuclear cells cultures under spontaneous and BCG- or PHA-stimulated conditions, serum concentrations of TGF-β2, IgA, IgG, IgM, IgE, and salivary IgA were evaluated. Results: The spontaneous production of TNF-α, IL-6, and IL-10, the PHA-stimulated production of IL-6, and the serum TGF-β2, IgA, and IgG were increased in samples from CF patients. Healthy subjects had a higher production of TNF-α in response to BCG. Conclusion: Although CF patients appeared clinically stable, the results of their peripheral blood examinations demonstrated an impact on the immune system. Copyright © 2013 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. All rights reserved. 89 1 40 47 O'Sullivan, B.P., Freedman, S.D., Cystic fibrosis (2009) Lancet, 373, pp. 1891-1904 Cheung, J.C., Kim Chiaw, P., Pasyk, S., Bear, C.E., Molecular basis for the ATPase activity of CFTR (2008) Arch Biochem Biophys, 476, pp. 95-100 Rottner, M., Freyssinet, J.M., Martínez, M.C., Mechanisms of the noxious inflammatory cycle in cystic fibrosis (2009) Respir Res, 10, p. 23 Cohen, T.S., Prince, A., Cystic fibrosis: A mucosal immunodeficiency syndrome (2012) Nat Med, 18, pp. 509-519 Beutler, E., (1986) Red Cell Metabolism, p. 126. , editor. New York: Churchill Livingstone Emmendörffer, A., Hecht, M., Lohmann-Matthes, M.L., Roesler, J., A fast and easy method to determine the production of reactive oxygen intermediates by human and murine phagocytes using dihydrorhodamine 123 (1990) J Immunol Methods, 131, pp. 269-275 Richardson, M.P., Ayliffe, M.J., Helbert, M., Davies, E.G., A simple flow cytometry assay using dihydrorhodamine for the measurement of the neutrophil respiratory burst in whole blood: Comparison with the quantitative nitrobluetetrazolium test (1998) J Immunol Methods, 219, pp. 187-193 Gaines, H., Andersson, L., Biberfeld, G., A new method for measuring lymphoproliferation at the single-cell level in whole blood cultures by flow cytometry (1996) J Immunol Methods, 195, pp. 63-72 Boncoeur, E., Criq, V.S., Bonvin, E., Roque, T., Henrion-Caude, A., Gruenert, D.C., Oxidative stress induces extracellular signalregulated kinase 1/2 mitogen-activated protein kinase in cystic fibrosis lung epithelial cells: Potential mechanism for excessive IL-8 expression (2008) Int J Biochem Cell Biol, 40, pp. 432-446 Mangione, S., Patel, D.D., Levin, B.R., Fiel, S.B., Erythrocytic glutathione in cystic fibrosis. A possible marker of pulmonary dysfunction (1994) Chest, 105, pp. 1470-1473 Lands, L.C., Grey, V., Smountas, A.A., Kramer, V.G., McKenna, D., Lymphocyte glutathione levels in children with cystic fibrosis (1999) Chest, 116, pp. 201-205 Gao, L., Kim, K.J., Yankaskas, J.R., Forman, H.J., Abnormal glutathione transport in cystic fibrosis airway epithelia (1999) Am J Physiol, 277, pp. L113-L118 Norman, D., Elborn, J.S., Cordon, S.M., Rayner, R.J., Wiseman, M.S., Hiller, E.J., Plasma tumour necrosis factor alpha in cystic fibrosis (1991) Thorax, 46, pp. 91-95 Balough, K., McCubbin, M., Weinberger, M., Smits, W., Ahrens, R., Fick, R., The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis (1995) Pediatr Pulmonol, 20, pp. 63-70 Bonfield, T.L., Panuska, J.R., Konstan, M.W., Hilliard, K.A., Hilliard, J.B., Ghnaim, H., Inflammatory cytokines in cystic fibrosis lungs (1995) Am J Respir Crit Care Med, 152, pp. 2111-2118 Osika, E., Cavaillon, J.M., Chadelat, K., Boule, M., Fitting, C., Tournier, G., Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease (1999) Eur Respir J, 14, pp. 339-346 Karpati, F., Hjelte, F.L., Wretlind, B., TNF-alpha and IL-8 in consecutive sputum samples from cystic fibrosis patients during antibiotic treatment (2000) Scand J Infect Dis, 32, pp. 75-79 Pukhalsky, A.L., Kapranov, N.I., Kalashnikova, E.A., Shmarina, G.V., Shabalova, L.A., Kokarovtseva, S.N., Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection (1999) Mediators Inflamm, 8, pp. 159-167 Moser, C., Kjaergaard, S., Pressler, T., Kharazmi, A., Koch, C., Høiby, N., The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type (2000) APMIS, 108, pp. 329-335 Wojnarowski, C., Frischer, T., Hofbauer, E., Grabner, C., Mosgoeller, W., Eichler, I., Cytokine expression in bronchial biopsies of cystic fibrosis patients with and without acute exacerbation (1999) Eur Respir J, 14, pp. 1136-1144 Noah, T.L., Black, H.R., Cheng, P.W., Wood, R.E., Leigh, M.W., Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis (1997) J Infect Dis, 175, pp. 638-647 Nixon, L.S., Yung, B., Bell, S.C., Elborn, J.S., Shale, D.J., Circulating immunoreactive interleukin-6 in cystic fibrosis (1998) Am J Respir Crit Care Med, 157, pp. 1764-1769 Nichols, D., Chmiel, J., Berger, M., Chronic inflammation in the cystic fibrosis lung: Alterations in inter-and intracellular signaling (2008) Clin Rev Allergy Immunol, 34, pp. 146-162 Moss, R.B., Bocian, R.C., Hsu, Y.P., Dong, Y.J., Kemna, M., Wei, T., Reduced IL-10 secretion by CD4+ T lymphocytes expressing mutant cystic fibrosis transmembrane conductance regulator (CFTR) (1996) Clin Exp Immunol, 106, pp. 374-388 Rosensweig, J.N., Omori, M., Page, K., Potter, C.J., Perlman, E.J., Thorgeirsson, S.S., Transforming growth factor-beta1 in plasma and liver of children with liver disease (1998) Pediatr Res, 44, pp. 402-409 South, M.A., Warwick, W.J., Wolheim, F.A., Good, R.A., The IgA system. 3. IgA levels in the serum and saliva of pediatric patients-evidence for a local immunological system (1967) J Pediatr, 71, pp. 645-653 Gugler, E., Pallavicini, J.C., Swedlow, H., Zipkin, I., Agnese, P.A., Immunological studies of submaxillary saliva from patients with cystic fibrosis and from normal children (1968) J Pediatr, 73, pp. 548-559 Hodson, M.E., Morris, L., Batten, J.C., Serum immunoglobulins and immunoglobulin G subclasses in cystic fibrosis related to the clinical state of the patient (1988) Eur Respir J, 1, pp. 701-705 Matthews Jr., W.J., Williams, M., Oliphint, B., Geha, R., Colten, H.R., Hypogammaglobulinemia in patients with cystic fibrosis (1980) N Engl J Med, 302, pp. 245-249 Wheeler, W.B., Williams, M., Matthews Jr., W.J., Colten, H.R., Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: A 5-year longitudinal study (1984) J Pediatr, 104, pp. 695-699 Harrison, F., Microbial ecology of the cystic fibrosis lung (2007) Microbiology, 153, pp. 917-923 Griffith, D.E., Aksamit, T., Brown-Elliott, B.A., Catanzaro, A., Daley, C., Gordin, F., An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases (2007) Am J Respir Crit Care Med, 175, pp. 367-416 Kremer, T.M., Zwerdling, R.G., Michelson, P.H., O'Sullivan, P., Intensive care management of the patient with cystic fibrosis (2008) J Intensive Care Med, 23, pp. 159-177 Costerton, J.W., Stewart, P.S., Greenberg, E.P., Bacterial biofilms: A common cause of persistent infections (1999) Science, 284, pp. 1318-1322 Ottenhoff, T.H., New pathways of protective and pathological host defense to mycobacteria (2012) Trends Microbiol, 20, pp. 419-428 Pier, G.B., The challenges and promises of new therapies for cystic fibrosis (2012) J Exp Med, 209, pp. 1235-1239